DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Johannsen M, Flörcken A, Bex A. et al.
Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysis.
Eur Urol 2009;
55: 1430-1438
DOI: 10.1016/j.eururo.2008.10.021.
We do not assume any responsibility for the contents of the web pages of other providers.